Clinical trial
Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by…
NCT00421083 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00421083 |
|---|---|
| Title | Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Assess Efficacy and Safety of Tadalafil (LY450190) in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | ICOS Corporation Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Erectile Dysfunction, Spinal Cord Injuries |
| Intervention type | Drug |
| Interventions | tadalafil |
| Enrollment | 180 |
| Start date | Sep 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Jan 11, 2007 |
| Last update posted | Oct 25, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: